Lymphokine-activated killer (LAK) cells, primarily derived from NK cells and T-lymphocytes, are activated by interleukin-2 (IL-2) and exhibit potent cytotoxic activity against tumor cells [272, 273]. Here, IL2 is linked to neoplasm.